Please ensure Javascript is enabled for purposes of website accessibility

Why Adeptus Health Shares Are Selling Off 14.4% Today

By Todd Campbell – Sep 7, 2016 at 12:05PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CEO Thomas S. Hall will step down from the company within the next year.

Image source: Getty Images.

What happened

After announcing the planned retirement of CEO Thomas S. Hall, shares of Adeptus Health (ADPT) are down 14.4% at 11:30 a.m. EDT.

So what

Adeptus Health is the biggest operator of freestanding emergency rooms in America and Hall has been at the helm during a period that has seen the company go from a private company operating 12 facilities to a public company operating 97 facilities with roughly $600 million in annualized quarterly revenue.

The departure of Hall won't be immediate. He will remain CEO until either the board of directors settles on a successor or the first half of 2017. He will also continue to serve as chairman of Adeptus Health's board until the end of his current term next year. 

Hall's retirement comes after Adeptus Health shares sold off sharply earlier this summer following management's announcement of lower-than-expected second-quarter results, including adjusted earnings per share of $0.48, which was below industry watchers' $0.51 estimate.

Now what

Richard Covert, vice chairman of Adeptus Health's board, said,  "We [the board] intend to identify a leader who will build on this momentum, creating enhanced value for Adeptus stockholders, our partners, employees, and the communities in which we operate."

The company didn't disclose a timeline for choosing a successor or whether it would consider entertaining merger and acquisition offers, so investors will need to keep an eye on the board's progress in future quarterly conference calls.

Currently, Adeptus Health is guiding for sales of between $640 million to $670 million and adjusted EPS of at least $2.55 in 2016, but while the company is growing and profitable, its shares are arguably fairly valued. Its price-to-earnings ratio is about 15, which is in the ballpark of hospital operators.

ADPT PE Ratio (Forward) Chart

ADPT PE Ratio (Forward) data by YCharts.

Overall, a change at the top could unlock value that kick-starts shares, but I'm going to stay on the sidelines for now and see how the company's financial results come in over the next couple of quarters.

Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may have positions in the companies mentioned. Like this article? Follow him on Twitter where he goes by the handle @ebcapital to see more articles like this. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Adeptus Health Inc. Stock Quote
Adeptus Health Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.